What is the share price of Torrent Pharmaceuticals Ltd (TORNTPHARM) today?
The share price of TORNTPHARM as on 19th March 2026 is ₹4236.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
The past returns of Torrent Pharmaceuticals Ltd (TORNTPHARM) share are- Past 1 week: -3.54%
- Past 1 month: 1.12%
- Past 3 months: 14.09%
- Past 6 months: 20.24%
- Past 1 year: 36.79%
- Past 3 years: 179.62%
- Past 5 years: 262.46%
What are the peers or stocks similar to Torrent Pharmaceuticals Ltd (TORNTPHARM)?
The peers or stocks similar to Torrent Pharmaceuticals Ltd (TORNTPHARM) include:What is the dividend yield % of Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
The current dividend yield of Torrent Pharmaceuticals Ltd (TORNTPHARM) is 0.75.What is the market cap of Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹145169.40 Cr as of 19th March 2026.What is the 52 week high and low of Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
The 52-week high of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹4482.90 and the 52-week low is ₹3049.20.What is the PE and PB ratio of Torrent Pharmaceuticals Ltd (TORNTPHARM) stock?
The P/E (price-to-earnings) ratio of Torrent Pharmaceuticals Ltd (TORNTPHARM) is 75.96. The P/B (price-to-book) ratio is 19.12.Which sector does Torrent Pharmaceuticals Ltd (TORNTPHARM) belong to?
Torrent Pharmaceuticals Ltd (TORNTPHARM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Torrent Pharmaceuticals Ltd (TORNTPHARM) shares?
You can directly buy Torrent Pharmaceuticals Ltd (TORNTPHARM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Torrent Pharmaceuticals Ltd
TORNTPHARM Share Price
NSE₹4,236.601.23% (-52.70)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TORNTPHARM Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TORNTPHARM Performance & Key Metrics
TORNTPHARM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 63.89 | 19.12 | 0.75% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.95 | 5.68 | 0.59% |
81%
Analysts have suggested that investors can buy this stock
from 27 analysts
Price Upside
Earnings Growth
Rev. Growth
TORNTPHARM Company Profile
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.
SUNPHARMA
PE Ratio
39.04
39.04
1Y Return
1.75%
1.75%
Buy Reco %
94.12
94.12
DRREDDY
PE Ratio
19.06
19.06
1Y Return
11.27%
11.27%
Buy Reco %
51.61
51.61
LUPIN
PE Ratio
32.07
32.07
1Y Return
13.16%
13.16%
Buy Reco %
72.22
72.22
CIPLA
PE Ratio
19.43
19.43
1Y Return
15.92%
15.92%
Buy Reco %
54.84
54.84
ZYDUSLIFE
PE Ratio
20.00
20.00
1Y Return
0.28%
0.28%
Buy Reco %
50.00
50.00
TORNTPHARM Sentiment Analysis
TORNTPHARM Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
TORNTPHARM Stock Summary · November 2025
The company demonstrated robust financial performance with a 14% revenue increase, largely fueled by strong growth in branded markets like India and Brazil, despite facing a 5% decline in Germany due to supply disruptions. Optimism surrounds the chronic therapies segment, which outperformed the market with a 13% growth, supported by a promising pipeline of 65 molecules awaiting approval. However, challenges persist in the U.S. market, where a lack of recent product launches has hindered profitability. Strategic plans include expanding the sales force and enhancing market coverage, particularly in chronic therapies, while navigating operational adjustments and potential pricing pressures in key markets. The pursuit of opportunities in the semaglutide market remains a focal point, despite regulatory uncertainties and ongoing litigation.
TORNTPHARM Stock Growth Drivers
TORNTPHARM Stock Growth Drivers
7Strong Financial Performance
Torrent Pharmaceuticals reported robust financial results for Q2 FY'26, with total revenues reaching Rs. 3,302
Regulatory Approvals and Strategic Initiatives
The company received important regulatory approvals from the Competition Commission of India and the Competition
TORNTPHARM Stock Challenges
TORNTPHARM Stock Challenges
5Decline in German Revenue
The company's operations in Germany have faced significant challenges, with revenues declining by 5% to
Foreign Exchange Loss
The company reported a foreign exchange loss of Rs. 39 crores, which has negatively affected
TORNTPHARM Forecast
TORNTPHARM Forecasts
Price
Revenue
Earnings
TORNTPHARM Share Price Forecast
TORNTPHARM Share Price Forecast
2026
Current
₹4,289.30
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹4,289.30
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
TORNTPHARM Company Revenue Forecast
TORNTPHARM Company Revenue Forecast
2025
Current
₹11.54
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹11.54
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
TORNTPHARM Stock EPS (Earnings Per Share) Forecast
TORNTPHARM Stock EPS (Earnings Per Share) Forecast
2025
Current
₹56.47
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹56.47
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
TORNTPHARM
TORNTPHARM
Income
Balance Sheet
Cash Flow
Quarterly Normal View
TORNTPHARM Income Statement
TORNTPHARM Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,686.00 | 2,787.00 | 2,776.00 | 2,883.00 | 2,873.00 | 2,842.00 | 2,941.00 | 3,141.00 | 3,275.00 | 3,290.00 | ||||||||||
Operating & Other expenses | 1,835.00 | 1,863.00 | 1,862.00 | 1,955.00 | 1,950.00 | 1,895.00 | 2,019.00 | 2,146.00 | 2,232.00 | 2,225.00 | ||||||||||
EBITDA | 851.00 | 924.00 | 914.00 | 928.00 | 923.00 | 947.00 | 922.00 | 995.00 | 1,043.00 | 1,065.00 | ||||||||||
| Depreciation/Amortization | 201.00 | 213.00 | 203.00 | 197.00 | 198.00 | 199.00 | 201.00 | 201.00 | 204.00 | 206.00 | ||||||||||
| PBIT | 650.00 | 711.00 | 711.00 | 731.00 | 725.00 | 748.00 | 721.00 | 794.00 | 839.00 | 859.00 | ||||||||||
| Interest & Other Items | 91.00 | 80.00 | 80.00 | 75.00 | 64.00 | 57.00 | 56.00 | 56.00 | 48.00 | 45.00 | ||||||||||
| PBT | 559.00 | 631.00 | 631.00 | 656.00 | 661.00 | 691.00 | 665.00 | 738.00 | 791.00 | 814.00 | ||||||||||
| Taxes & Other Items | 173.00 | 188.00 | 182.00 | 199.00 | 208.00 | 188.00 | 167.00 | 190.00 | 200.00 | 179.00 | ||||||||||
| Net Income | 386.00 | 443.00 | 449.00 | 457.00 | 453.00 | 503.00 | 498.00 | 548.00 | 591.00 | 635.00 | ||||||||||
| EPS | 11.39 | 13.10 | 13.27 | 13.51 | 13.37 | 14.88 | 14.71 | 16.19 | 17.54 | 18.77 |
TORNTPHARM Company Updates
FY 2026FY 2026
Investor Presentation
Feb 13PDF
Nov 7PDF
Jul 28PDF
Jun 30PDF
TORNTPHARM Stock Peers
TORNTPHARM Past Performance & Peer Comparison
TORNTPHARM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd | 75.96 | 19.12 | 0.75% |
| Sun Pharmaceutical Industries Ltd | 39.04 | 5.89 | 0.90% |
| Dr Reddy's Laboratories Ltd | 19.06 | 3.18 | 0.62% |
| Lupin Ltd | 32.07 | 6.08 | 0.52% |
TORNTPHARM Stock Price Comparison
Compare TORNTPHARM with any stock or ETFCompare TORNTPHARM with any stock or ETF
TORNTPHARM
TORNTPHARM Holdings
TORNTPHARM Shareholdings
TORNTPHARM Promoter Holdings Trend
TORNTPHARM Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
TORNTPHARM Institutional Holdings Trend
TORNTPHARM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TORNTPHARM Shareholding Pattern
TORNTPHARM Shareholding Pattern
TORNTPHARM Shareholding History
TORNTPHARM Shareholding History
Foreign Institutions
Mutual Funds Invested in TORNTPHARM
Mutual Funds Invested in TORNTPHARM
No mutual funds holding trends are available
Top 5 Mutual Funds holding Torrent Pharmaceuticals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9385% | Percentage of the fund’s portfolio invested in the stock 3.44% | Change in the portfolio weight of the stock over the last 3 months 0.52% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 13/55 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2880% | Percentage of the fund’s portfolio invested in the stock 1.29% | Change in the portfolio weight of the stock over the last 3 months 0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 23/62 (+2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1976% | Percentage of the fund’s portfolio invested in the stock 1.25% | Change in the portfolio weight of the stock over the last 3 months 0.18% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/62 (+4) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing TORNTPHARM stock
smallcases containing TORNTPHARM stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Torrent Pharmaceuticals Ltd
TORNTPHARM Events
TORNTPHARM Events
TORNTPHARM Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TORNTPHARM has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.75%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.46 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TORNTPHARM Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TORNTPHARM has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.75%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.46 every year
TORNTPHARM Upcoming Dividends
TORNTPHARM Upcoming Dividends
No upcoming dividends are available
TORNTPHARM Past Dividends
TORNTPHARM Past Dividends
Cash Dividend
Ex DateEx DateFeb 18, 2026
Interim
Interim | Div/Share: ₹29.00
Dividend/Share
₹29.00
Ex DateEx Date
Feb 18, 2026
Cash Dividend
Ex DateEx DateJun 20, 2025
Final
Final | Div/Share: ₹6.00
Dividend/Share
₹6.00
Ex DateEx Date
Jun 20, 2025
Cash Dividend
Ex DateEx DateJan 31, 2025
Interim
Interim | Div/Share: ₹26.00
Dividend/Share
₹26.00
Ex DateEx Date
Jan 31, 2025
Cash Dividend
Ex DateEx DateJun 21, 2024
Final
Final | Div/Share: ₹6.00
Dividend/Share
₹6.00
Ex DateEx Date
Jun 21, 2024
Cash Dividend
Ex DateEx DateFeb 12, 2024
Interim
Interim | Div/Share: ₹22.00
Dividend/Share
₹22.00
Ex DateEx Date
Feb 12, 2024
TORNTPHARM Stock News & Opinions
TORNTPHARM Stock News & Opinions
Articles & Videos
Spotlight
Torrent Pharmaceuticals Ltd soars 0.79%, rises for fifth straight session
Torrent Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 4432.5, up 0.79% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.31% on the day, quoting at 25504.3. The Sensex is at 82333.07, up 0.13%. Torrent Pharmaceuticals Ltd has risen around 10.88% in last one month. Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has risen around 5.55% in last one month and is currently quoting at 22632.05, up 1.62% on the day. The volume in the stock stood at 2.01 lakh shares today, compared to the daily average of 3.99 lakh shares in last one month. The benchmark March futures contract for the stock is quoting at Rs 4417.6, up 0.64% on the day. Torrent Pharmaceuticals Ltd is up 48.39% in last one year as compared to a 13.13% spurt in NIFTY and a 13.84% spurt in the Nifty Pharma index.The PE of the stock is 66.66 based on TTM earnings ending December 25.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Spotlight
Torrent Pharmaceuticals Ltd soars 4.69%
Torrent Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quoting at Rs 4269.3, up 4.69% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.33% on the day, quoting at 25554. The Sensex is at 82870.82, up 0.3%. Torrent Pharmaceuticals Ltd has risen around 4.47% in last one month. Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has risen around 1.09% in last one month and is currently quoting at 22194.9, up 0.82% on the day. The volume in the stock stood at 12.03 lakh shares today, compared to the daily average of 3.05 lakh shares in last one month. The benchmark February futures contract for the stock is quoting at Rs 4229, up 4.71% on the day. Torrent Pharmaceuticals Ltd is up 38.7% in last one year as compared to a 11.3% spurt in NIFTY and a 6.17% spurt in the Nifty Pharma index.The PE of the stock is 64.61 based on TTM earnings ending September 25.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Torrent Pharmaceuticals consolidated net profit rises 26.24% in the December 2025 quarter
Net profit of Torrent Pharmaceuticals rose 26.24% to Rs 635.00 crore in the quarter ended December 2025 as against Rs 503.00 crore during the previous quarter ended December 2024. Sales rose 17.70% to Rs 3251.00 crore in the quarter ended December 2025 as against Rs 2762.00 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3251.002762.00 18 OPM %33.4733.09 - PBDT1030.00890.00 16 PBT824.00691.00 19 NP635.00503.00 26 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Torrent Pharmaceuticals to pay interim dividend
Torrent Pharmaceuticals announced that interim dividend of Rs 29 per equity share of Rs 5 will be paid on or around 06 March 2026. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Torrent Pharmaceuticals recommends interim dividend
Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 13 February 2026, inter alia, have recommended the interim dividend of Rs 29 per equity Share (i.e. 580%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Torrent Pharmaceuticals announces board meeting date
Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Torrent Pharmaceuticals' Dahej unit clears USFDA inspection
Torrent Pharmaceuticals announced that the USFDA inspected its Dahej manufacturing unit from 19 January 2026 to 23 January 2026. The inspection concluded with Zero observations. Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Torrent Pharmaceuticals Ltd soars 1.74%, Gains for third straight session
Torrent Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quoting at Rs 4088, up 1.74% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 25522.15. The Sensex is at 83010.66, down 0.67%. Torrent Pharmaceuticals Ltd has added around 7.13% in last one month. Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has added around 3.29% in last one month and is currently quoting at 22217.05, down 0.2% on the day. The volume in the stock stood at 2.43 lakh shares today, compared to the daily average of 2.11 lakh shares in last one month. The benchmark January futures contract for the stock is quoting at Rs 4087.1, up 1.65% on the day. Torrent Pharmaceuticals Ltd is up 29.19% in last one year as compared to a 9.33% gain in NIFTY and a 0.04% gain in the Nifty Pharma index.The PE of the stock is 63.73 based on TTM earnings ending September 25.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Torrent Pharma approves NCD issuance up to Rs 12,500 cr
Torrent Pharma has approved the issuance of Secured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) aggregating upto Rs 12,500 crore in one or more tranches on private placement basis.Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
Torrent Pharma credit rating unchanged as India Ratings reaffirms AA+
Torrent Pharmaceuticals said India Ratings and Research has reaffirmed the credit rating of the company's existing banking facilities, issuer rating and non-convertible debentures at IND AA+ with a stable outlook. The rating agency has also assigned a short-term rating of IND A1+ to Torrent Pharma's proposed commercial paper programme, indicating a strong degree of safety with respect to timely servicing of financial obligations. The company's securities transfer and stakeholders relationship committee will meet on 5 January 2026 to consider the issuance of secured non-convertible debentures through a private placement, within the borrowing limits already approved by the board in July 2025. Torrent Pharma is the flagship company of the Torrent Group. It is ranked 7th in the Indian Pharmaceuticals Market and is amongst the Top 5 in the therapeutics segments of Cardiovascular (CV), Gastro Intestinal (GI), Central Nervous System (CNS) and Cosmo-Dermatology. It is a specialty-focused company with ~76% of its revenues in India from chronic & sub-chronic therapies. It has presence in 50+ countries and is ranked No. 1 amongst the Indian pharma companies in Brazil and Germany. Torrent has 8 manufacturing facilities, of which 5 are USFDA approved. On a consolidated basis, the company's net profit rose 30.46% to Rs 591 crore while net sales rose 14.66% to Rs 3246 crore in Q2 September 2025 over Q2 September 2024. Shares of Torrent Pharmaceuticals rose 0.96% to settle at Rs 3884.85 on Friday, 2 January 2026. Powered by Capital Market - Live
2 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 7.44%, vs industry avg of 9.88%
Over the last 5 years, market share decreased from 3.17% to 2.72%
Over the last 5 years, net income has grown at a yearly rate of 13.28%, vs industry avg of 19.69%